Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELIEF: BLU-5937 in chronic cough
NCT03979638Phase 2Terminated
- Sponsor
- GSK
- Start
- Jul 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of camlipixant in refractory chronic cough (RCC), sponsored by GSK. Started Jul 2019; status: terminated.
02
Drugs
camlipixant
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on NCT03979638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03979638.